SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma enters into non-exclusive voluntary licensing agreement with MSD

25 Jul 2026 Evaluate

Aurobindo Pharma has entered into a non-exclusive voluntary licensing agreement with MSD (trade name of Merck & Co., Inc., Rahway, N.J., USA. Aurobindo Pharma is among a select group of global generic manufacturers to have signed this agreement. The royalty-free agreement will enable supply of generic alimatravir to cover 129 Low- & Middle-Income Countries (LMICs) which account for the majority of new HIV diagnoses globally, subject to applicable regulatory approvals and requirements. 

Executing these agreements before Phase 3 trial enrollment is completed is a first in HIV prevention and is intended to enable the right scale-up where Aurobindo Pharma is licensed to manufacture and supply generic alimatravir, which will meet internationally recognized standards following regulatory approvals.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1531.50 7.60 (0.50%)
24-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1941.00
Dr. Reddys Labs. 1152.60
Cipla 1410.90
Lupin 2369.45
Zydus Lifesciences 1108.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: